Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29:
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents
Diego García-Compeán; Ramesh Kumar; Ángel Noe del Cueto-Aguilera; Héctor Jesús Maldonado-Garza; Jesús Zacarías Villarreal-Pérez;
Ann Hepatol. 2023;28:
Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
Diego García-Compeán; Emanuela Orsi; Tsutomu Nishida; Ramesh Kumar;
10.1016/j.aohep.2021.100648